Chinese medicine composition for treating phthisis and use thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- SHENYANG HONGQI PHARMA
- Publication Date
- 2006-08-09
- Estimated Expiration
- Not applicable · inactive patent
Abstract
Description
technical field
[0001] The invention relates to a Chinese patent medicine, in particular to a traditional Chinese medicine composition and application for treating pulmonary tuberculosis with Chinese medicine as the main component. Background technique
[0002] Tuberculosis is a common and difficult disease, which is a relatively common chronic infectious disease caused by Mycobacterium tuberculosis infection. Tuberculosis can occur in various tissues and organs of the human body, but the lung is the most common, and tuberculosis that occurs in the lung is called pulmonary tuberculosis. The general clinical use of Western medicine and chemotherapy for the treatment of tuberculosis at home and abroad. The western medicine for modern clinical treatment of pulmonary tuberculosis mainly includes isoniazid: its main toxic and side effects are excitability, insomnia, peripheral nerve inflammation, and occasionally liver function damage; rifampicin: its main toxic and side effects...